Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

242 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy.
Riva G, Luppi M, Quadrelli C, Barozzi P, Basso S, Vallerini D, Zanetti E, Morselli M, Forghieri F, Maccaferri M, Paolini A, Del Giovane C, D'Amico R, Marasca R, Narni F, Iacobucci I, Martinelli G, Baccarani M, Comoli P, Potenza L. Riva G, et al. Among authors: basso s. Blood Cancer J. 2011 Jul;1(7):e30. doi: 10.1038/bcj.2011.26. Epub 2011 Jul 22. Blood Cancer J. 2011. PMID: 22829186 Free PMC article. No abstract available.
Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term imatinib mesylate treatment.
Riva G, Luppi M, Barozzi P, Quadrelli C, Basso S, Vallerini D, Zanetti E, Morselli M, Forghieri F, Maccaferri M, Volzone F, Del Giovane C, D'Amico R, Locatelli F, Torelli G, Comoli P, Potenza L. Riva G, et al. Among authors: basso s. Blood. 2010 Feb 25;115(8):1512-8. doi: 10.1182/blood-2009-06-230391. Epub 2009 Dec 10. Blood. 2010. PMID: 20007806 Free article. Clinical Trial.
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL.
Riva G, Luppi M, Lagreca I, Barozzi P, Quadrelli C, Vallerini D, Zanetti E, Basso S, Forghieri F, Morselli M, Maccaferri M, Paolini A, Fantuzzi V, Messerotti A, Maffei R, Iacobucci I, Martinelli G, Marasca R, Narni F, Comoli P, Potenza L. Riva G, et al. Among authors: basso s. Br J Haematol. 2014 Jan;164(2):299-302. doi: 10.1111/bjh.12612. Epub 2013 Oct 18. Br J Haematol. 2014. PMID: 24134676 Free article. No abstract available.
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors.
Comoli P, Basso S, Riva G, Barozzi P, Guido I, Gurrado A, Quartuccio G, Rubert L, Lagreca I, Vallerini D, Forghieri F, Morselli M, Bresciani P, Cuoghi A, Paolini A, Colaci E, Marasca R, Cuneo A, Iughetti L, Trenti T, Narni F, Foà R, Zecca M, Luppi M, Potenza L. Comoli P, et al. Among authors: basso s. Blood. 2017 Feb 2;129(5):582-586. doi: 10.1182/blood-2016-07-731091. Epub 2016 Dec 7. Blood. 2017. PMID: 27927646 Free PMC article.
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia.
Forghieri F, Riva G, Lagreca I, Barozzi P, Vallerini D, Morselli M, Paolini A, Bresciani P, Colaci E, Maccaferri M, Gilioli A, Nasillo V, Messerotti A, Pioli V, Arletti L, Giusti D, Bettelli F, Celli M, Donatelli F, Corradini G, Basso S, Gurrado A, Cellini M, Trenti T, Marasca R, Narni F, Martelli MP, Falini B, Potenza L, Luppi M, Comoli P. Forghieri F, et al. Among authors: basso s. Oncotarget. 2019 Jan 25;10(8):869-882. doi: 10.18632/oncotarget.26617. eCollection 2019 Jan 25. Oncotarget. 2019. PMID: 30783516 Free PMC article.
The Role of T Cell Immunity in Monoclonal Gammopathy and Multiple Myeloma: From Immunopathogenesis to Novel Therapeutic Approaches.
Lagreca I, Riva G, Nasillo V, Barozzi P, Castelli I, Basso S, Bettelli F, Giusti D, Cuoghi A, Bresciani P, Messerotti A, Gilioli A, Pioli V, Colasante C, Vallerini D, Paolini A, Maccaferri M, Donatelli F, Forghieri F, Morselli M, Colaci E, Leonardi G, Marasca R, Potenza L, Manfredini R, Tagliafico E, Trenti T, Comoli P, Luppi M. Lagreca I, et al. Among authors: basso s. Int J Mol Sci. 2022 May 8;23(9):5242. doi: 10.3390/ijms23095242. Int J Mol Sci. 2022. PMID: 35563634 Free PMC article. Review.
Prognostic Relevance of Multi-Antigenic Myeloma-Specific T-Cell Assay in Patients with Monoclonal Gammopathies.
Lagreca I, Nasillo V, Barozzi P, Castelli I, Basso S, Castellano S, Paolini A, Maccaferri M, Colaci E, Vallerini D, Natali P, Debbia D, Pirotti T, Ottomano AM, Maffei R, Bettelli F, Giusti D, Messerotti A, Gilioli A, Pioli V, Leonardi G, Forghieri F, Bresciani P, Cuoghi A, Morselli M, Manfredini R, Longo G, Candoni A, Marasca R, Potenza L, Tagliafico E, Trenti T, Comoli P, Luppi M, Riva G. Lagreca I, et al. Among authors: basso s. Cancers (Basel). 2023 Feb 3;15(3):972. doi: 10.3390/cancers15030972. Cancers (Basel). 2023. PMID: 36765928 Free PMC article.
Preclinical Validation of an Advanced Therapy Medicinal Product Based on Cytotoxic T Lymphocytes Specific for Mutated Nucleophosmin (NPM1mut) for the Treatment of NPM1mut-Acute Myeloid Leukemia.
De Cicco M, Lagreca I, Basso S, Barozzi P, Muscianisi S, Bianco A, Riva G, Di Vincenzo S, Pulvirenti C, Sapuppo D, Siciliano M, Rosti V, Candoni A, Zecca M, Forghieri F, Luppi M, Comoli P. De Cicco M, et al. Among authors: basso s. Cancers (Basel). 2023 May 12;15(10):2731. doi: 10.3390/cancers15102731. Cancers (Basel). 2023. PMID: 37345068 Free PMC article.
Infusion of autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication.
Comoli P, Labirio M, Basso S, Baldanti F, Grossi P, Furione M, Viganò M, Fiocchi R, Rossi G, Ginevri F, Gridelli B, Moretta A, Montagna D, Locatelli F, Gerna G, Maccario R. Comoli P, et al. Among authors: basso s. Blood. 2002 Apr 1;99(7):2592-8. doi: 10.1182/blood.v99.7.2592. Blood. 2002. PMID: 11895798 Free article.
242 results